Launois R, Le Moine JG, Huynh MT, Boissier MC. Analyse de l'impact budgétaire de la prise en charge de la polyarthrite rhumatoïde en 1ère, 2ème et 3ème ligne de traitement, après échec d'un traitement de fond. Presented at the French Society of Rheumatology 24th Annual Congress; December 11, 2011. Paris, France.
Oldenburg CE, Sy A, Srinivasan M, Toutain-Kidd CM, Mascarenhas J, Ravindran M, Rajaraman R, Esterberg EJ, Chidambaram JD, Acharya NR, Lietman TM, Zegans ME. Pre-existing blindness in a cohort of patients with bacterial keratitis. Br J Ophthalmol. 2011 Dec;95(11):1612-3. doi: 10.1136/bjophthalmol-2011-300270.
Herring WL, Herrmann JW. A stochastic dynamic program for the single-day surgery scheduling problem. IIE Trans Healthc Syst Eng. 2011 Dec 1;1(4):213-25.
Trask PC, Mitra D, Iyer S, Candrilli SD, Kaye JA. Treatment response patterns and related prognostic indicators in chronic myeloid leukemia patients: a multi-country medical record review study. Poster presented at the 53rd American Society of Hematology (ASH) Annual Meeting and Exposition; December 2011. San Diego, CA. [abstract] Blood. 2011 Nov 18; 118(21):3131. doi: 10.1182/blood.V118.21.3131.3131
Meyers JL, Yu YF, Davis KL. Medicare fee-for-service enrollees with acute myelogenous leukemia: an analysis of treatment patterns and patient survival. Poster presented at the 53rd American Society of Hematology (ASH) Annual Meeting and Exposition; December 2011. San Diego, CA. [abstract] Blood. 2011 Nov 18; 118(21):505. doi: 10.1182/blood.V118.21.505.505
Stull DE, Houghton KF, Kulich K. Innovative methods for demonstrating value for pharmaceutical products: rethinking data analysis with implications for study design and personalized medicine. Presented at the International Society for Pharmacoeconomics and Outcomes Research; November 5, 2011. Madrid, Spain.
Stull DE, Houghton KF, Filonenko A. Study heterogeneity in treatment response in women with idiopathic menorrhagia treated with levonorgestrel-releasing intrauterine system (LGN-IUS): application of innovative methods to identify differential response. Presented at the 2011 ISPOR 14th Annual European Congress; November 5, 2011. Madrid, Spain.
Domingo P, Hill A, Gostkorzewicz J, Brogan A. Comparative cost-effectiveness analysis between darunavir/r and other protease inhibitors in the treatment of HIV-1 infection in naïve patients in Spain. Poster presented at the Third National GESIDA Congress; November 2011. Seville, Spain. doi: 10.1016 / j.eimc.2012.11.001
Stull DE, Houghton K. Examining variability in depression among pre-retirees: innovative analytic methods applied to observational data. Poster presented at the 2011 ISPOR 14th Annual European Congress; November 9, 2011. [abstract] Value Health. 2011 Nov; 14(7):A301.
Stull DE, Wiklund I, Gale R, Capkun-Niggli G, Houghton K, Jones P. Application of latent growth and growth mixture modeling to identify and characterize differential responders to treatment for COPD. Contemp Clin Trials. 2011 Nov 1;32(6):818-28.
Stull DE, Houghton KF, Gale R, Wiklund I, Capkun-Niggli G, Jones P. Application of innovative methods to identify and characterize differential responders in clinical trials of COPD: the use of mixture models. Poster presented at the 2011 ISPOR 14th Annual European Congress; November 2011. Madrid, Spain. [abstract] Value Health. 2011 Nov; 14(7):A501-2.
Palsgrove A, Houghton KF, Hareendran A, Schaefer M, Setyawan J, Mocarski M, Carson R, Make B. The development of the early morning symptoms of COPD instrument (EMSCI). Poster presented at the 2011 ISPOR 14th Annual European Congress; November 16, 2011. [abstract] Value Health. 2011 Nov; 14(7):A496-7.
Mitra D, Trask P, Iyer S, Candrilli S, Kaye J. A multi-country retrospective study of patient characteristics and treatment patterns in chronic myeloid leukemia. Poster presented at the 2011 ISPOR 14th Annual European Congress; November 10, 2011. [abstract] Value Health. 2011 Nov; 14(7):A468.
Antela A, Llibre JM, Lopez Bernaldo De Quiros JC, Portilla J, Gallois A, Campbell A, Penafiel J, Brogan AJ, Talbird SE. HIV Treatment Cost-Effectiveness Study Group. An economic model to assess the cost-effectiveness of early treatment initiation for people with HIV infection in Spain. Poster presented at the Third National GESIDA Congress; November 2011. Seville, Spain.
Candrilli SD, Bell CF, Davis KL. Recent trends in muscular dystrophy-related inpatient care among pediatric patients in the United States. Poster presented at the 2011 ISPOR 14th Annual European Congress; November 2011. Madrid, Spain. [abstract] Value Health. 2011 Nov; 14(7):A320.
Earnshaw SR, McDade CL, Zanotti G, Farkouh R, Strutton D. Cost-effectiveness of 2+1 dosing of 13-valent pneumococcal conjugate vaccine compared with 2+1 dosing of 10-valent conjugate vaccine in preventing pneumococcal disease in Canada. Poster presented at the 2011 ISPOR 14th Annual European Congress; November 9, 2011. [abstract] Value Health. 2011 Nov; 14(7):A275.
Taylor TN, Farkouh RA, Graham JB, Colligs A, Lindemann M, Lynen R, Candrilli SD. Potential reduction in neural tube defects associated with use of metafolin-fortified oral contraceptives in the United States. Am J Obstet Gynecol. 2011 Nov 1;205(5):460.e1-8.
Karve S, Misurski D, Miller J, Davis KL. Costs of sequelae associated with invasive meningococcal disease: findings from a US managed care population. Health Outcomes Res Med. 2011 Nov 1;2(4):e215-26.
Karve S, Markowitz M, Panish J, Candrilli S, Cosmatos I, Alphs L. Assessing health care utilization and costs among hospital-discharged patients with schizophrenia. Poster presented at the 2011 US Psychiatric and Mental Health Congress; November 2011.
Pandya N, Wei W, Kilpatrick B, Meyers JL, Davis KL. Too many finger sticks for nothing? A study of sliding scale insulin use among elderly nursing home residents with type 2 diabetes. Poster presented at the Annual Meeting and Convention of the American Society of Consultant Pharmacists; November 2011.
Markowitz M, Karve S, Panish J, Candrilli S, Cosmatos I, Alphs L. Evaluating antipsychotic adherence patterns among Medicaid-enrolled hospital-discharged patients with schizophrenia. Poster presented at the Psychiatric and Mental Health Congress; November 2011.
Davis AE, Ladner D, Friedewald J, Mehrotra S. Ameliorating geographic disparities in kidney transplantation rates via optimization approaches. Poster presented at the Annual Meeting of the Institute for Operations Research and Management Science; November 2011. Previously presented at the American Transplant Congress.
Davis AE, Ladner D, Friedewald J, Mehrotra S. Ameliorating geographic disparities in kidney transplantation rates via optimization approaches. Poster presented at the American Society of Nephrologists; November 2011. Previously presented at the American Transplant Congress.
Hicks KA, Karve S, Vlahiotis A, Frazee S, Tian Y, Earnshaw SR. Estimation of increases in direct medical expenditures associated with medication nonadherence and potential savings from increased adherence. Poster presented at the 2011 ISPOR 14th Annual European Congress; November 9, 2011. [abstract] Value Health. 2011 Nov; 14(7):A343-4.
Lucas A, Armbruster B. Optimal HIV testing by risk group. Presented at the 33rd Annual North American Meeting of the Society for Medical Decision Making; October 24, 2011. Chicago, IL.
Talbird S, Knerer G, Hausdorff W, Taylor T, Frostad CR. Reply to Strutton et al.: response to “Outcomes and costs associated with PHiD-CV, a new protein D conjugate pneumococcal vaccine, in four countries”. Vaccine. 2011 Oct 1;29(44):7591-2.
Wolowacz SE, Samuel M, Brennan VK, Jasso-Mosqueda J, Van Gelder IC. The cost of illness of atrial fibrillation: a systematic review of the recent literature. Europace. 2011 Oct 1;13(10):1375-85.
Cohen C, Davis KL, Meyers JL. Effect of daily antiretroviral pill burden on health care utilization and costs in United States Medicaid enrollees with HIV. Poster presented at the 13th European AIDS Conference; October 2011.
Deniz B, Brogan AJ, Miller JD, Talbird SE, Thompson JR. Projections using decision-analytic modeling of long-term clinical value of telaprevir for the treatment of HCV patients who had failed prior peginterferon/ribavirin treatment. Poster presented at the 62nd Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) Conference; November 2011. San Francisco, CA. [abstract] Hepatology. 2011 Oct 1; 54(Suppl. 1):802A-3A.
Deniz B, Brogan AJ, Miller JD, Talbird SE, Thompson J. Cost-effectiveness assessment of telaprevir combination treatment compared to pegylated-interferon + ribavirin alone in the management of chronic hepatitis C in patients who failed a prior pegylated-interferon + ribavirin treatment. Poster presented at the Annual Scientific Meeting of the American College of Gastroenterology; October 2011.
Loftus EV, Hodgkins P, Davis KL, Yen L. Economic burden of diverticulitis complications in a Unites States managed care population. Poster presented at the Annual Scientific Meeting of the American College of Gastroenterology; October 2011.
Chevrou-Severac H, Ochoa JB, Mauskopf JA, Candrilli SD, Graham JB, Drawert S, Greenberg N. Immunonutrition for gastrointestinal cancer patients: an effective and cost-savings intervention. Poster presented at the 24th Annual Meeting of the European Society of Intensive Care Medicine; October 2011. Previously presented at the 33rd Congress of the European Society for Clinical Nutrition and Metabolism.
Oldenburg CE, Keenan JD, Cevallos V, Chan MF, Acharya NR, Gaynor BD, McLeod SD, Esterberg EJ, Porco TC, Lietman TM. Microbiological cure times in acanthamoeba keratitis. Eye (Lond). 2011 Sep;25(9):1155-60. doi: 10.1038/eye.2011.126
Kattan MW, Earnshaw SR, McDade CL, Black LK, Andriole GL. Cost effectiveness of chemoprevention for prostate cancer with dutasteride in a high-risk population based on results from the REDUCE clinical trial. Appl Health Econ Health Policy. 2011 Sep 1;9(5):305-15.
Stull DE, van Hanswijck de Jonge P, Houghton K, Kocun C, Sandor DW. Development of a frequent heartburn index. Qual Life Res. 2011 Sep 1;20(7):1023-34.
Cohen C, Davis KL, Meyers JL. Association between daily antiretroviral pill burden and hospitalization risk in a Medicaid population with HIV. Poster presented at the 51st Interscience Conference on Antimicrobial Agents and Chemotherapy; September 2011.
Hirsch IB, Xu Y, Davis KL, Calingaert B. Patient factors associated with glucagonlike peptide 1 receptor agonist use with and without insulin. Endocr Pract. 2011 Sep 1;17(5):707-16.
Chevrou-Severac H, Mauskopf JA, Candrilli SD, Ochoa JB. Immunonutrition for gastrointestinal cancer patients: an effective and cost-savings intervention. Poster presented at the 33rd Congress of the European Society for Clinical Nutrition and Metabolism; September 2011. Gothenburg, Sweden.
Dalal AA, Candrilli SD, Davis KL. Outcomes and costs associated with initial maintenance therapy with fluticasone propionate-salmeterol xinafoate 250 ?g/50 ?g combination versus tiotropium in commercially insured patients with copd. Manag Care. 2011 Aug 1;20(8):46-55.
Herring WL, Herrmann JW. Scheduling impatient jobs with diminishing rewards: the impact of deteriorating survival probabilities on mass casualty incident triage. Presented at the 5th Multidisciplinary International Conference on Scheduling: Theory and Applications (MISTA 2011); August 2011. Phoenix, AZ. [abstract] J Sched. 2011 Aug; 14:587-91.
Rahman MQ, Abeysinghe SS, Kelly S, Roskell NS, Shannon PR, Abdlseaed AA, Montgomery DMI. Persistence of glaucoma medical therapy in the Glasgow Glaucoma Database. Br J Ophthalmol. 2011 Jul 1;95(7):966-70.
Mauskopf J, Walter J, Birt J, Bowman L, Copley-Merriman C, Drummond M. Differences among formulary submission guidelines: implications for health technology assessment. Int J Technol Assess Health Care. 2011 Jul 1;27(3):261-70.
McLellan AR, Wolowacz SE, Zimovetz EA, Beard SM, Lock S, McCrink L, Adekunle F, Roberts D. Fracture liaison services for the evaluation and management of patients with osteoporotic fracture: a cost-effectiveness evaluation based on data collected over 8 years of service provision. Osteoporos Int. 2011 Jul 1;22(7):2083-98.
Brogan AJ, Talbird SE, Cohen C. Cost-effectiveness of nucleoside reverse transcriptase inhibitor pairs in efavirenz-based regimens for treatment-naïve adults with HIV infection in the United States. Value Health. 2011 Jul 1;14(5):657-554.
Pandya N, Wei W, Kilpatrick BS, Meyers JL, Davis KL. Burden of sliding scale insulin use in elderly long-term care residents with type 2 diabetes. Poster presented at the National Conference of the National Association of Directors of Nursing Administration in Long Term Care; July 2011.
Aragãgo F, Vera J, Vaz Pinto I, Talbird SE, Brogan AJ. Economic evaluation of early antiretroviral treatment for HIV-1 infected individuals in Portugal. Poster presented at the 6th Annual Conference of the International AIDS Society; July 2011.
Varadhachary GR, Spector Y, Abbruzzese JL, Rosenwald S, Wang H, Aharonov R, Carlson HR, Cohen D, Karanth S, Macinskas J, Lenzi R, Chajut A, Edmonston TB, Raber MN. Prospective gene signature study using microRNA to identify the tissue of origin in patients with carcinoma of unknown primary. Clin Cancer Res. 2011 Jun 15;17(12):4063-70. doi: 10.1158/1078-0432.CCR-10-2599
Earnshaw S. Assessing the economic value of companion diagnostics: best practice. Presented at the 2011 World Theranostic Conference; June 14, 2011. Geneva, Switzerland.
Earnshaw SR. Assessing economic value of companion diagnostics: best practices. Poster presented at the World Theranostics Congress; June 2011.
Sikirica V, Bapat B, Candrilli SD, Davis KL, Wilson M, Johns A. The inpatient burden of abdominal and gynecological adhesiolysis in the US. BMC Surg. 2011 Jun 1;11:13.
